Advanced therapeutic approaches in sarcoglycanopathies
Current Opinion in Pharmacology · 2024
DOI: 10.1016/j.coph.2024.102459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Pharmacology, 2024. Verfasst von Martina Scano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Padova, Via U. Bassi 58/B, 35131 Padova, Italy. Hauptthemen laut MEDLINE: Sarcoglycanopathies, Sarcoglycans. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Muscular Dystrophy Association, Fondazione Telethon, Association Française contre les Myopathies.
Abstract (Originalsprache)
Sarcoglycanopathies are rare autosomal recessive diseases belonging to the family of limb-girdle muscular dystrophies. They are caused by mutations in the genes coding for α-, β-, γ-, and δ-sarcoglycan. The mutations impair the assembly of a key structural complex, which normally protects the sarcolemma of striated muscle from contraction-derived stress. Although heterogeneous, sarcoglycanopathies are characterized by progressive muscle degeneration, increased serum creatine kinase levels, loss of ambulation often during adolescence, and variable cardio-respiratory impairment. Genetic defects can impair sarcoglycan synthesis or produce a protein that is defective in folding. There is currently no effective treatment available; however, both gene replacement strategy and small molecule-based approaches show great promise and have entered or are starting to enter clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Padova, Via U. Bassi 58/B, 35131 Padova, Italy.
- Department of Biomedical Sciences, University of Padova, Via U. Bassi 58/B, 35131 Padova, Italy. Electronic address: dorianna.sandona@unipd.it.
Förderung
- Muscular Dystrophy Association
- Fondazione Telethon
- Association Française contre les Myopathies
- AFM-Telethon
Zitieren
APA
Scano, M., Benetollo, A., Dalla Barba, F., & Sandonà, D. (2024). Advanced therapeutic approaches in sarcoglycanopathies. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2024.102459
Vancouver
Scano M, Benetollo A, Dalla Barba F, Sandonà D. Advanced therapeutic approaches in sarcoglycanopathies. Current Opinion in Pharmacology. 2024. doi:10.1016/j.coph.2024.102459
BibTeX
@article{Scano2024,
author = {Scano, Martina and Benetollo, Alberto and Dalla Barba, Francesco and Sandonà, Dorianna},
title = {Advanced therapeutic approaches in sarcoglycanopathies},
journal = {Current Opinion in Pharmacology},
year = {2024},
doi = {10.1016/j.coph.2024.102459}
}
EUVIMED